KMDA.TA - Kamada Ltd.
| Previous Close | 2,634.00 |
| Open | 2,634.00 |
| Bid | 2,549.00 x 346500 |
| Ask | 1.00 x 57900 |
| Day's Range | 2,550.00 - 2,643.00 |
| 52 Week Range | 1,732.00 - 2,729.00 |
| Volume | 211,772 |
| Avg. Volume | 79,901 |
| Market Cap | 1B |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 2,917.62 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Thomson Reuters StreetEvents
Edited Transcript of KMDA.TA earnings conference call or presentation 13-Nov-19 1:30pm GMT
Q3 2019 Kamada Ltd Earnings Call
- Insider Monkey
Did Hedge Funds Drop The Ball On Kamada Ltd (KMDA) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 52% and 49% respectively. Hedge funds' top 3 stock picks returned 39.1% this year and beat the S&P […]
- Thomson Reuters StreetEvents
Edited Transcript of KMDA.TA earnings conference call or presentation 6-Aug-19 12:30pm GMT
Q2 2019 Kamada Ltd Earnings Call
Motley FoolKamada Ltd. (KMDA) Q2 2019 Earnings Call Transcript
KMDA earnings call for the period ending June 30, 2019.
Motley FoolKamada Ltd. (KMDA) Q1 2019 Earnings Call Transcript
KMDA earnings call for the period ending March 31, 2019.
- Associated Press
Kamada: 1Q Earnings Snapshot
The Rehovot, Israel-based company said it had net income of 12 cents per share. Earnings, adjusted for stock option expense, came to 13 cents per share. The biopharmaceutical posted revenue of $26.8 million ...
- Benzinga
A Preview Of Kamada's Q1 Earnings
Kamada Ltd. (NASDAQ: KMDA ) releases its next round of earnings this Tuesday, May 14. Here's Benzinga's essential guide to Kamada's first-quarter earnings report. Earnings and Revenue Analysts covering ...
- Associated Press
Kamada: 4Q Earnings Snapshot
On a per-share basis, the Rehovot, Israel-based company said it had profit of 44 cents. Earnings, adjusted for stock option expense, were 45 cents per share. The biopharmaceutical posted revenue of $48.2 ...
